In 2017, a new drug came onto the market that radically improved therapy for adult sufferers of Type 2 diabetes. That new treatment is a once-a-week self-injectable dose of Ozempic, and it contains a newly developed drug called semaglutide.
Now, the drug company Novartis that developed Ozempic has released a pill-form of semaglutide that can be taken daily, called Rybelsus.
Rybelsus comes in the form of white to light yellow oval-shaped pills debossed with the strength on one side. There are three dosages – 3mg, 7mg or 14mg.
Your prescribing doctor will usually start you off on the lower dosage, and can then increase according to the reactions.
Five common misbeliefs about COVID-19 and vaccines
Do people let false claims about health issues get in their way? It is quite disturbing to learn that reliable
Read More »